EGFR-targeting Drugs in Combination With Cytotoxic Agents: From Bench to Bedside, a Contrasted Reality

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6604373
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Targeting the IDO1 Pathway in Cancer: From Bench to Bedside

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

From Bench to Bedside

Circulation Journal
MedicineCardiovascular MedicineCardiology
2008English

Ebola From Bedside to Bench

Cell
BiochemistryGeneticsMolecular Biology
2019English

CXCR2: From Bench to Bedside

Frontiers in Immunology
AllergyImmunology
2012English

Sepsis: From Bench to Bedside

Clinics
Medicine
2008English

Immunotherapy in ALL: From Bench to Bedside

Egyptian Journal of Hematology and Bone Marrow Transplantation
2017English

Sphingolipids in Inflammation: From Bench to Bedside

Mediators of Inflammation
ImmunologyCell Biology
2016English

Inflammatory Disease: From Bench to Bedside

Autoimmunity
AllergyImmunology
2010English

Wireless Neuromodulation: From Bench to Bedside

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy